Cargando…

Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174

Detalles Bibliográficos
Autores principales:	Benucci, Maurizio, Damiani, Arianna, Bandinelli, Francesca, Russo, Edda, Li Gobbi, Francesca, Grossi, Valentina, Amedei, Amedeo, Infantino, Maria, Manfredi, Mariangela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965674/ https://www.ncbi.nlm.nih.gov/pubmed/36836609 http://dx.doi.org/10.3390/jpm13020168

Ejemplares similares

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease
por: Benucci, Maurizio, et al.
Publicado: (2022)

Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars
por: Ebbers, Hans C., et al.
Publicado: (2020)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2018)

Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4
por: Emery, Paul, et al.
Publicado: (2017)

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci, Maurizio, et al.
Publicado: (2018)

Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept
por: Cho, Ick Hyun, et al.
Publicado: (2016)

Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
por: Ebbers, Hans C., et al.
Publicado: (2019)

Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
por: Benucci, Maurizio, et al.
Publicado: (2019)

On the decay of 110Sb, 111Sb, 112Sb, 113Sb and 114Sb
por: Sunier, J W, et al.
Publicado: (1970)

Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2022)

The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases
por: Bruni, Cosimo, et al.
Publicado: (2020)

Between Elemental Match and Mismatch: From K(12)Ge(3.5)Sb(6) to Salts of (Ge(2)Sb(2))(2−), (Ge(4)Sb(12))(4−), and (Ge(4)Sb(14))(4−)
por: Beuthert, Katrin, et al.
Publicado: (2022)

Phase Equilibria and Crystal Growth in the Alkali Antimonate Systems Sb(2)O(4)–NaSbO(3/) Sb(2)O(4)–KSbO(3/), and Sb(2)O(4)–NaSbO(3)–NaF
por: Waring, J. L., et al.
Publicado: (1976)

Two sb or not two sb?
por: Kado, M, et al.
Publicado: (2000)

A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects
por: Lee, Yoon Jung, et al.
Publicado: (2016)

The switcher and the scheduler
por: Arnault, C, et al.
Publicado: (1987)

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
por: Benucci, Maurizio, et al.
Publicado: (2020)

52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2017)

Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study
por: Parisi, Simone, et al.
Publicado: (2022)

Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
por: Yoo, Wan-Hee, et al.
Publicado: (2022)

Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
por: Benucci, Maurizio, et al.
Publicado: (2021)

A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190
por: Glover, Mark, et al.
Publicado: (2010)

Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study
por: Luciano, Nicoletta, et al.
Publicado: (2022)

Rb(2)Sb(4)O(11)
por: Kalpana, Govindaraasan, et al.
Publicado: (2009)

Ba(2)Sb(4)GeS(10)
por: Geng, Lei
Publicado: (2013)

Synthesis and Electronic Structure of Mid-Infrared Absorbing Cu(3)SbSe(4) and Cu(x)SbSe(4) Nanocrystals
por: Moser, Annina, et al.
Publicado: (2023)

Sorghum Phytochrome B Inhibits Flowering in Long Days by Activating Expression of SbPRR37 and SbGHD7, Repressors of SbEHD1, SbCN8 and SbCN12
por: Yang, Shanshan, et al.
Publicado: (2014)

Smooth termination of intruder bands in $^{109}$Sb and $^{51}$Sb
por: Schnare, H, et al.
Publicado: (1996)

Synthesis and Crystal Structure of the Zintl Phases NaSrSb, NaBaSb and NaEuSb
por: Wang, Yi, et al.
Publicado: (2023)

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
por: Benucci, Maurizio, et al.
Publicado: (2020)

Crystal structure of Ba(5)In(4)Sb(6)
por: Pan, Ming-Yan, et al.
Publicado: (2015)

Metals in medicine project: Investigation of the treatment of Leishmaniases with antimony containing drug compounds using perturbed angular correlation spectroscopy with parent Isotopes $^{116}$Sb, $^{118}$Sb, $^{120}$Sb, ($^{128}$Sb), $^{130}$Sb
por: Shaapan, R M, et al.
Publicado: (2012)

Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis
por: Lachowicz, Joanna I., et al.
Publicado: (2022)

Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine
por: Infantino, Maria, et al.
Publicado: (2022)

Metal-Semiconductor AsSb-Al(0.6)Ga(0.4)As(0.97)Sb(0.03) Metamaterial
por: Bert, Nikolay, et al.
Publicado: (2022)

The effect of Mn(2)Sb(2) and Mn(2)Sb secondary phases on magnetism in (GaMn)Sb thin films
por: Calderón, Jorge A., et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
por: Manfredi, Mariangela, et al.
Publicado: (2023)

The ESSnuSB Accumulator
por: Wildner, Elena
Publicado: (2018)

Site and Buildings (SB)
Publicado: (1964)

Cannot write session to /tmp/vufind_sessions/sess_msjqrfkehmmj0sbvbhd1029es9